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Abstract
Identifying external factors that can be used to control neural stem cells division and their differentiation to neurons,
astrocytes and oligodendrocytes is of high scientific and clinical interest. Here we show that the Nogo-66 receptor
interacting protein LINGO-1 is a potent regulator of neural stem cell maturation to neurons. LINGO-1 is expressed by cortical
neural stem cells from E14 mouse embryos and inhibition of LINGO-1 during the first days of neural stem cell differentiation
results in decreased neuronal maturation. Compared to neurons in control cultures, which after 6 days of differentiation
have long extending neurites, neurons in cultures treated with anti-LINGO-1 antibodies retain an immature, round
phenotype with only very short processes. Furthermore, neutralization of LINGO-1 results in a threefold increase in bIII
tubulin-positive cells compared to untreated control cultures. By using BrdU incorporation assays we show that the
immature neurons in LINGO-1 neutralized cultures are dividing neuroblasts. In contrast to control cultures, in which no cells
were double positive for bIII tubulin and BrdU, 36% of the neurons in cultures treated with anti-LINGO-1 antibodies were
proliferating after three days of differentiation. TUNEL assays revealed that the amount of cells going through apoptosis
during the early phase of differentiation was significantly decreased in cultures treated with anti-LINGO-1 antibodies
compared to untreated control cultures. Taken together, our results demonstrate a novel role for LINGO-1 in neural stem
cell differentiation to neurons and suggest a possibility to use LINGO-1 inhibitors to compensate for neuronal cell loss in the
injured brain.
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Introduction
Several important breakthroughs during recent years have
raised a hope that stem cell-based therapies could be used to
restore function and integrity after acute brain injury and other
disorders of the central nervous system. In order to develop
effective and safe regenerative treatments it is however necessary
to identify factors that could be used to control differentiation,
proliferation and survival of neural stem and progenitor cells
(NSPCs). In addition to intrinsic regulation, the presence of
different extrinsic factors including soluble compounds, membrane
bound molecules and extracellular matrix has been shown to
influence NSPCs in various ways. For example fibroblast growth
factor (FGF2) [1,2], epidermal growth factor (EGF) [3,4], Notch
[5] and sonic hedgehog (SHH) [6] all promote proliferation and
prevent differentiation of NSPCs. Ciliary neurotrophic factor
(CNTF), bone morphogenic protein (BMP) and leukemia
inhibitory factor (LIF) has been demonstrated to shift the
differentiation of NSPCs into an astrocytic fate [2,7] whereas
addition of tri-iodothyronine (T3) or insulin-like growth factor 1
(IGF-1) increase the number of oligodendocytes in NSPC cultures
[2,8]. Neuronal-specific induction is more difficult to achieve.
Activation of the Wnt pathway has been demonstrated to direct
neural cortical progenitor cells to differentiate to neurons in vitro
and to promote hippocampal neurogenesis in vivo but the Wnt
ligands has also been shown to induce proliferation of neural stem
cells [9,10,11,12,13,14]. Platelet derived growth factor (PDGF)
was earlier suggested to be involved in neuronal differentiation,
but has more recently been shown to rather promote proliferation
of precursor cells [15,16,17].
Leucine rich repeat and Ig domain containing Nogo receptor
interacting protein-1 (LINGO-1) is a nervous system-specific
transmembraneproteinthatisassociated with the Nogo-66 receptor
complex known to be a potent inhibitor of axonal sprouting and
myelination [18,19,20,21,22]. In addition, LINGO-1 has been
shown to negatively regulate the differentiation of oligodendrocyte
precursorcells(OPCs)tomyelinatingoligodendrocytes[23].Results
from both cell culture experiments and animal studies provide
evidence that blocking endogenous LINGO-1 by LINGO-1
antagonists or gene knockouts promote oligodendrocytic differen-
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of multiple sclerosis [23]. Furthermore, it has been suggested that
LINGO-1 inhibition increase neuronal survival by activation of the
PI3K/Aktpathways [24].The role ofLINGO-1 forneuralstem cell
regulation has however not previously been evaluated. In the
present study we demonstrate a function of LINGO-1 in neuronal
differentiation of NSPCs.
Results
LINGO-1 expression increases during neural stem cell
differentiation
Western blot analysis was used to investigate the expression of
LINGO-1 during NSPC differentiation. Cell lysates were prepared
from NSPCs proliferating in the presence of the mitogens EGF and
FGF2 and from NSPCs that have differentiated in the absence of
the mitogens for 1, 3, 6 and 9 days. The lysates were
immunoprecipitated with a LINGO-1 specific antibody (LINGO-
1 ab) and following transfer, the membrane was hybridized with
another LINGO-1 specific antibody. Figure 1A show that LINGO-
1 is present in proliferating, undifferentiated NSPCs (Day 0)
although the protein level is low. The expression of LINGO-1
increases as the cells differentiate and the maximum expression of
LINGO-1 was detected in lysates from cells that have differentiated
for the longest time (Day 9). Quantification of the LINGO-1
expression show a nine-fold increase in the expression at 9 days of
differentiation compared to Day 0 (Figure 1B).
In order to investigate the expression of LINGO-1 in specific
cell types during NSPC differentiation we performed double
immunostainings using antibodies against LINGO-1 and specific
markers for NSPCs, neurons, oligodendrocytes and astrocytes.
Proliferating NSPCs were fixed at day 0 and stained with
antibodies against nestin and LINGO-1. We found that 9161%
(mean6sem) of the cells at day 0 were nestin positive and that
10060% (mean6sem) of these nestin-positive NSPCs expresses
LINGO-1 (Figure 1C–E). Differentiated cultures were fixed 6 days
after growth factor withdrawal and stained with antibodies against
LINGO-1 and ßIII tubulin (neurons), CNPase (oligodendrocytes)
or GFAP (astrocytes). In line with previous studies [18,20,23], our
immunostainings demonstrate that 10060% (mean6sem) of both
the neurons and oligodendrocytes, but 060% (mean6sem) of the
astrocytes, express LINGO-1 (Figure 1F–N). In order to test the
specificity of the LINGO-1 antibody we performed performed
double stainings with the Novartis antibody and a LINGO-1
antibody purchased from Abcam. The staining demonstrates that
the two antibodies identify the same LINGO-1 expressing cells in
the culture (Figure S1).
Neurons in LINGO-1 neutralized cultures retain an
immature phenotype
Our western blot data show that LINGO-1 is expressed in
NSPCs, but that the expression increases during the differentia-
tion. We next sought to investigate the effect of LINGO-1
neutralization on NSPC differentiation. Differentiation of NSPC
cultures was initiated by mitogen removal and cells were cultured
in medium only (controls) or medium containing 100 mg/ml anti-
LINGO-1 antibodies (LINGO-1ab) for 1, 3 or 6 days prior to
fixation. Parallel cell cultures were immunostained against markers
specific for neurons (bIII tubulin), astrocytes (GFAP) and
oligodendrocytes (CNPase) (Figure 2). Our results show that
neutralization of LINGO-1 has a dramatic effect on neuronal
differentiation (Figure 2A, B). Compared to bIII tubulin-positive
cells in untreated control cultures, which after 6 days of
differentiation have a rather mature neuronal phenotype with
long extending neurites (Figure 2A), bIII tubulin-positive cells in
cultures treated with LINGO-1 ab retain an immature, round
phenotype with only very short processes (Figure 2B). In contrast,
Figure 1. LINGO-1 expression increases during neural stem cell
differentiation. A) Western blot analysis was used to study LINGO-1
expression during NSPC differentiation. Cell lysates from proliferating
cells (Day 0) and NSPCs differentiating for 1–9 days was immunopre-
cipitated with anti-LINGO-1 antibodies (Novartis) and blotted with
LINGO-1 ab (Abcam). LINGO-1 is present in both proliferating and
differentiated NSPCs, but the expression increases during the differen-
tiation. B) Protein quantification show a 9-fold increase in LINGO-1
expression in cultures differentiated for 9 days compared to prolifer-
ating NSPCs (Day 0). Double immunostainings with specific antibodies
against LINGO-1 (C–N) and nestin (C–E), bIIItubulin (F–H), GFAP (I–K) or
CNPase (L–N) show that NSPCs, neurons and oligodendrocytes express
LINGO-1, but not astrocytes. The NSPC cultures were fixed at day 0 (C–E)
and the differentiated cultures were fixed at day 6 after mitogen
withdrawal (F–N). Scale bars=20 mm.
doi:10.1371/journal.pone.0029771.g001
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neutralization of LINGO-1 as GFAP-positive cells in control
cultures (Figure 2C) and cultures treated with LINGO-1 ab had
identical phenotypes. Furthermore, we found that CNPase-positive
oligodendrocytes appeared only slightly more differentiated after 6
days when cultured in the presence of LINGO-1 ab compared to
untreated controls (Figure 2E,F).Ourresults show that LINGO-1is
especially important for early neuronal differentiation and that
neutralization of LINGO-1 result in decreased neuronal matura-
tion. To verify that the effect of the LINGO-1 neutralization was
specific, a control antibody (100 mg/ml anti-lysozyme) was included
as a control (Figure S2). Since the effect of the control antibody was
indistinguishablefromplainmedium,untreatedcultureswasusedas
controls in all additional experiments. Furthermore, we performed
experiments with different concentrations of the LINGO-1
antibody. We found that already at the lower concentrations,
1 mg/ml and 10 mg/ml, we had a clear affect of the LINGO-1
antibody on neuronal maturation (the neurons had shorter
processes). The effect was however more pronounced in cell
cultures treated with 100 mg/ml LINGO-1 ab. The effect on
neuronal differentiation in cultures treated with 1000 mg/ml
LINGO-1 antibody was similar to 100 mg/ml, but the cells were
more often found in clusters (Figure S2).
Neutralization of LINGO-1 results in an increased number
of neurons
To elucidate if the percentage of neurons, astrocytes and
oligodendrocytes in the differentiated NSPC cultures were influ-
enced by LINGO-1 neutralization, we counted the bIII tubulin,
GFAP and CNPase-positive cells in control cultures after 6 days of
differentiation in the absence or presence of LINGO-1 ab. The
percentage of positive cells to the total cell number is presented in
Figure3A.Wenoteda 3-foldincreaseofbIIItubulinpositivecellsin
LINGO-1 neutralized cultures (29.560.7% mean6sem) compared
to controlcultures (9.161.6% mean6sem)(Figure 3A). There was a
modest, but significant, increase in the percentage of GFAP-positive
cells in LINGO-1 neutralized cultures compared to untreated
control cultures, but no difference in the percentage of CNPase-
positive cells (Figure 3A). We have shown that astrocytes do not
express LINGO-1. It is however probable that early astrocytic
progenitor cells express the LINGO-1 which could explain the
Figure 2. LINGO-1 neutralization during NSCP differentiation
results in immature neurons. To investigate the effect of LINGO-1
neutralization on NSPC differentiation, NSPCs were cultured for 6 days
in the absence (A, C and E) or presence (B, D and F) of LINGO-1 ab
(Novartis) following mitogen withdrawal. The cells were fixed and
stained with specific antibodies against bIIItubulin (A–B), GFAP (C–D) or
CNPase (E–F). In control cultures (A) neurons were rather mature with
multiple, long extending processes, but in cultures treated with LINGO-
1 antibodies (B) the neurons had a more immature phenotype with only
one or two short processes. There was no distinct difference in
astrocyte staining (C–D) or oligodrocyte staining (E–F) between control
cultures and LINGO-1 inhibited cultures. Scale bars=20 mm.
doi:10.1371/journal.pone.0029771.g002
Figure 3. Neutralization of LINGO-1 leads to an increased
percentage of neurons. A) The number of neurons, astrocytes and
oligodendrocytes was counted and plotted as the ratio of specific
marker-positive cells to the total cell number (DAPI). After 6 days of
differentiation there was a 3-fold increase in the percentage of neurons
in LINGO-1 ab treated cultures compared to untreated controls. There
was only a modest, but significant, increase in the percentage of GFAP
positive cells and no difference was found in the percentage of CNPase
positive cells. B) Comparison of the percentage of mature and immature
neurons of the total number of bIIItubulin positive cells show a 7-fold
increase of immature cells in LINGO-1 ab treated cultures compared to
untreated control cultures after 6 days of differentiation. *** denotes
p,0,001, ** denotes p,0,01 and * denotes p,0,05.
doi:10.1371/journal.pone.0029771.g003
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Taken together, the morphology of the different cell types shown in
Figure 2 and the cell counting experiments shown in Figure 3
demonstrate that the neutralization of LINGO-1 during early
NSPC differentiation has a clear effect on neuronal maturation but
only a mild effect on glial maturation. We therefore decided to focus
on neuronal maturation in this study.
Next, we compared the percentage of mature and immature
neurons in control cultures and cultures treated with LINGO-1 ab
after 6 days of differentiation (Figure 3B). Neurons with multiple,
long extending processes were considered to be mature while
neurons with only one or two short processes and a round cell
body was considered to be immature. We found a striking
difference between the cultures. The percentage of immature
neurons in untreated control cultures was 12.062.2% (mean6-
sem) compared to 83.961.8% (mean6sem) in cultures that
received LINGO-1 ab during the differentiation period. The
percentage of mature neurons showed the opposite pattern with
88.062.2% (mean6sem) in the control cultures compared to
16.161.8% (mean6sem) in cultures treated with the antibody.
The 7-fold increase of immature cells in LINGO-1 neutralized
cultures further demonstrates the important role of LINGO-1 in
the differentiation of NSPCs into neurons.
Cell proliferation is increased in LINGO-1 neutralized
stem cell cultures
We next examined if neutralization of LINGO-1 influences the
proliferation of NSPCs. We first investigated the effect of LINGO-
1-blocking on the ability of the NSPCs to form neurospheres in the
presence or absence of the mitogens FGF2 and EGF. NSPC
neurosphere cultures were dissociated to single cell suspension and
10 NSPCs/ml was cultured for 8 days in medium containing
LINGO-1 ab, LINGO-1 ab+FGF2+EGF and control cultures
with FGF2+EGF or medium only. Neurospheres were only found
in cultures with FGF2 and EGF and there was no significant
difference in neurosphere number between the cultures with both
mitogens and LINGO-1 (20363 spheres/ml mean6sem) and
mitogens only (191613 spheres/ml mean6sem) indicating that
LINGO-1 neutralization does not affect proliferation of immature,
sphere forming neural stem cells.
To investigate whether LINGO-1 inhibition increase DNA
synthesis of progenitor cells during the first days of differentiation,
cell cultures were pulse-labeled with bromodeoxyuridine (BrdU) for
16 hours and stained with an anti-BrdU antibody (Figure 4A–E).
The BrdU incorporation in NSPC cultures grown in the presence of
FGF and EGF was 87.565.6% (mean6sem) (Day 0, Figure 4A). In
control cultures, differentiating in the absence of growth factors, the
percentage of cells that had incorporated BrdU decreased markedly
and after three days of differentiation only 5.060.5% (mean6sem)
were BrdU positive (Figure 4A–C). After one day of differentiation,
cultures treated with LINGO-1 ab had no significant increase in
BrdU incorporation compared to untreated control cultures, but
after 3 days of differentiation the increase in BrdU incorporation
was 3-fold (18.061.6% mean6sem, Figure 4A, D–E). At day 6, the
proliferationhad declined in the LINGO-1 neutralized cultures, but
there was still a significantly higher BrdU incorporation compared
to the untreated control cultures (11.060.8 and 7.060.8%
mean6sem respectively, Figure 4A).
To further clarify the mitogenic effect of LINGO-1 neutraliza-
tion during the first days of NSPC differentiation, we investigated
if treatment with LINGO-1 ab resulted in an increase in the total
cell number. For this purpose all the cells in the dish of LINGO-1
neutralized cultures and control cultures were collected by using a
cell scraper. The total number of cells was counted by using a
nuclear cell counter after 1, 3 and 6 days of differentiation
(Figure 4F). We found that neutralization of LINGO-1 did not
significantly increase the total cell number (Figure 4F). This could
be explained by the fact that only a low percentage of progenitor
cells are proliferating in the differentiating cell cultures, making the
result of a 3-fold increase in BrdU positive cells difficult to detect in
Figure 4. LINGO-1 neutralization promotes cell proliferation.
BrdU labeling was used to investigate the effect of LINGO-1
neutralization on cell proliferation (A–D). Cells were exposed to BrdU
for 16 hours prior to fixation and stained with specific antibodies
against BrdU (red) and DAPI (blue). E) The number of cells that had
incorporated BrdU was counted and plotted as the ratio of BrdU-
positive cells to the total cell count. F) The total cell number in anti-
LINGO-1 antibody treated and untreated control cultures were
measured at day 0, 1, 3 and 6 days of differentiation. The cells in
each dish were harvested using a cell scraper and counted using a
NucleoCounter
TM. The mean values of the total cell count/dish were
plotted. *** denotes p,0,001, ** denotes p,0,01 and * denotes p,0,05
and scale bars=20 mm.
doi:10.1371/journal.pone.0029771.g004
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blocking LINGO-1 has no direct effect on neural stem cell
expansion, but probably increase proliferation of one or several
types of neural progenitor cells.
LINGO-1 neutralization specifically increase proliferation
of neuroblasts
Our immunostainings show that neuroblasts do not differentiate
into mature neurons during 6 days of differentiation in the
presence of LINGO-1 ab. To investigate if LINGO-1 neutraliza-
tion has a specific effect on the proliferation of immature neurons,
NSPCs were differentiated in the absence or presence of LINGO-
1 ab, pulse-labeled with BrdU for 16 hours and stained with
antibodies against BrdU and bIII tubulin after fixation (Figure 5A–
J and Table 1). As we previously showed in Figure 4E, a very high
proportion of the NSPCs were BrdU-positive at the beginning of
the experiment, but these cells did not express neuronal markers
(Figure 5A–B and Table 1). Already after 3 days of differentiation,
the cells in the control cultures that expressed the neuronal marker
had a rather mature phenotype. We did not find any cells that
were double positive for bIII tubulin and BrdU, demonstrating
that the cells that had differentiated to neurons ceased to divide
(Figure 5C–D and Table 1). At day 6 after growth factor
withdrawal, the neurons were more mature, with several long,
extending processes, but also here devoid of BrdU incorporation
(Figure 5E–F and Table 1). In cultures treated with LINGO-1 ab
the results were different. After 3 days of differentiation
35.564.1% (mean6sem) of the cells expressing the neuronal
marker bIII tubulin were also positive for BrdU, showing that
LINGO-1 neutralization has a prominent effect on neuroblast
proliferation (Figure 5G–H and Table 1). After 6 days of
differentiation the percentage of proliferating immature neurons
had declined, but still 13.463.3% (mean6sem) of the neurons had
incorporated BrdU (Figure 5I–J and Table 1).
LINGO-1 neutralization increase cell survival of
differentiating neural stem cells
We next investigated if inhibition of LINGO-1, in addition to the
effect on proliferation, also has an effect on cell survival during the
first days of NSCP differentiation. Staining for dead cells using
TUNEL labeling, revealed a significant decrease in cell death in
LINGO-1 ab-treated cultures compared to control cultures already
after1dayofdifferentiation.After3daysofdifferentiationtherewas
an almost 2-fold decrease in TUNEL positive cells in the LINGO-1
neutralized cultures compared to control cultures (Figure 6A–E). In
addition to the TUNEL assay, we studied the phosphorylation of
PKB/c-Akt as a measurement of increased cell survival since
LINGO-1 neutralization previously has been indicated to result in a
sustained Akt-phosphorylation in retinal ganglion cells [24]. We
measured phosphorylated and total PKB/c-Akt in protein lysates
from parallel cell cultures differentiating in the absence or presence
of LINGO-1 ab for 1, 3 and 6 days by Western blot. The highest
level of phosphorylated PKB/c-Akt was found in cultures
differentiated for six days in the presence of LINGO-1 ab. We
could however not detect any clear differences in PKB/c-Akt
phosphorylation between LINGO-1 ab-treated cultures and control
cultures at the different time points (Figure 7A–B).
Discussion
Here we report a novel function for LINGO-1 in neural stem
cell differentiation, regulating the maturation of progenitor cells
differentiating along the neuronal lineage. Neutralization of
LINGO-1 during the first days of neural stem cell differentiation
results in a prominent decrease in neuronal maturation.
Compared to neurons in control cultures, which after 6 days of
differentiation have long extending neurites, neurons in cultures
Figure 5. Neutralization of LINGO-1 leads to an increased
percentage of proliferating neuroblasts. To investigate if the
immature neurons in LINGO-1 neutralized cultures proliferate, we
double-labeled the cells with specific antibodies against BrdU (red),
bIIItubulin (green) and DAPI (blue). NSPCs were fixed at day 0 (A–B) or
differentiated in only medium for 3 days (C–D) or for 6 days (E–F)
medium containing anti-LINGO-1 antibodies (G–J). BrdU was added to
the cultures 16 hours prior to fixation. Scale bars=20 mm.
doi:10.1371/journal.pone.0029771.g005
Table 1. LINGO-1 neutralization increases the percentage of
proliferating immature neurons.
Day 0 Day 3 Day 6
Control
a 0%60% 0%60% 0%60%
LINGO-1 inhibition
a N/A 35.5%64.1%*** 13.4%63.3%***
aThe number of BrdU-bIIItubulin double positive cells and total number of
bIIItubulin positive cells were counted and the proportion of dividing neurons
calculated. The results are expressed as means 6 standard error of the mean
(sem). ***=p,0.001.
doi:10.1371/journal.pone.0029771.t001
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with only very short processes. It has previously been reported
that LINGO-1 is a negative regulator of differentiation of OPCs
to mature, myelinating oligodendrocytes. Treatment of cultured
OPCs with LINGO-1 siRNA, dominant negative LINGO-1 or
LINGO-Fc, resulted in increased morphological differentiation
of the oligodendrocytes characterized by the abundance of
terminal membrane sheets [23]. In another study nerve growth
factor (NGF) was shown to regulate the expression of axonal
LINGO-1 and thereby the inhibition of oligodendrocyte
differentiation and myelinisation [20]. In contrast to these
findings, that demonstrate an important role for LINGO-1
during late oligodendrocyte maturation, we only detected minor
effects of LINGO-1 neutralization on early astrocyte and
oligodendrocyte maturation. Taken together, our results show
that LINGO-1 is central for the regulation of early neuronal
maturation, but might be less important for the glial cell fate
during the first days of NSPC differentiation. Importantly, it has
been demonstrated in a previous study that Myt1l, an early
marker for postmitotic neurons and a neurogenic transcription
factor known to enhance the maturation rate of neurons,
interacts with LINGO-1 [25].
LINGO-1 expression has been detected in the developing
mouse brain from day E16, and the level of LINGO-1 protein was
shown to increase from late embryogenesis to peak at P5 in the
cerebellum and at P21 in the anterior brain [25]. The components
of the Nogo receptor complex; LINGO-1, NgR1, p75
NTR and
TROY has been shown to coexist in the mouse brain at later
postnatal stages. However, the authors show that LINGO-1 is
expressed earlier during the development in the absence of NgR1,
indicating that LINGO-1 therefore may participate in other
activities in developing neurons separate from oligodendrocyte
maturation or axon extension [25]. More recently, Mathis et al.
demonstrated that migrating neural progenitor cells cultured from
the E15.5 mouse brain express both the Nogo receptor, LINGO-1,
TROY and p75
NTR [26]. In the adult brain LINGO-1 protein
levels are highest in hippocampus, neocortex and striatum, while
lower levels of LINGO-1 protein are found in cerebellum, pons,
olfactory bulb and spinal cord [25]. It has been suggested in
several reports that LINGO-1 mRNA is expressed in neurons and
oligodendrocytes, but not in astrocytes [18,20,23]. In a detailed
analysis of LINGO-1 expression in the brain, Llorens et al. found
LINGO-1 protein expression in a subset of neurons, but not in
myelinating, mature oligodendrocytes [25]. Moreover, Satoh et al.
reported that LINGO-1 is expressed in reactive astrocytes and
microglia in human brain tissue from multiple sclerosis (MS)
patients [27]. Our data demonstrate that LINGO-1 is expressed
by cortical neural stem cells from E14 mouse embryos, and that
the LINGO-1 protein expression increases as the stem cell cultures
differentiate. In NSPC cultures that have differentiated for 6 days
in the absence of EGF and FGF-2, LINGO-1 is selectively
expressed by neurons and oligodendrocytes and not by astrocytes.
Notably, at this time point the oligodendrocytes and neurons are
not fully mature.
In this investigation we neutralized LINGO-1 using an LINGO-
1 ab at a concentration of 100 mg/ml based on previous studies
and our initial results that this concentration effectively neutralizes
LINGO-1 without adverse effects [20,28,29]. To exclude any non-
Figure 6. Decreased number of TUNEL positive cells in cultures
treated with anti-LINGO-1 antibodies. TUNEL assay was performed
on NSPC and parallel cultures of cells differentiated for 1 and 3 days in
the absence or presence of LINGO-1 ab (A–D). Representative photos of
control cultures (A–B) and LINGO-1 neutralized cultures (C–D) at day 3
of differentiation, TUNEL (green) and DAPI (blue). E) Cells going through
apoptosis were counted and plotted as the ratio of the total number of
cells. *** denotes p,0,001, ** denotes p,0,01 and * denotes p,0,05
and scale bars=20 mm.
doi:10.1371/journal.pone.0029771.g006
Figure 7. LINGO-1 neutralization has no effect on PKB/c-Akt
phosphorylation. A) Western blot analysis was used to study PKB/c-
Akt phosphorylation in differentiating NSPCs in the absence or
presence of LINGO-1 ab. Total cell lysates were used for immunoblot-
ting with anti-PKB/c-Akt antibody (Akt) and anti-phosphorylated PKB/c-
Akt antibody (p-Akt). B) The ratio of phosphorylated Akt was measured
and plotted.
doi:10.1371/journal.pone.0029771.g007
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lysozyme) antibody of the same concentration in our first sets of
experiments. Since no effect of the control antibody was detected
on neuronal differentiation, we used plain medium as a control in
all following experiments.
Although, the influence of exogenous factors on differentiation
of NSPC has been addressed in several studies, the regulation of
the neuronal lineage is still unclear. In this study we demonstrate
that neutralization of LINGO-1 during the first days of NSPC
differentiation result in a 3-fold increase of bIII tubulin-positive
cells compared to untreated control cultures. In contrast, there was
only a modest increase in the percentage of GFAP positive cells in
LINGO-1 neutralized cultures compared to untreated control
cultures, and no difference was found in the percentage of CNPase
positive cells. By using the neurosphere assay we demonstrate that
LINGO-1 neutralization had no detectable effect on the ability of
neural stem cells to proliferate and form neurospheres. These
results further verify that LINGO-1 is primarily involved in the
regulation of neuronal differentiation.
Our BrdU incorporation analyzes show that the immature
neurons that are found in LINGO-1 neutralized cultures are
dividing neuroblasts. In control cultures there were no cells that
were double positive for bIII tubulin and BrdU after three or six
days of differentiation, demonstrating that stem cells that have
started to differentiate to neurons did no longer divide. In cultures
treated with LINGO-1 ab the results were completely different.
After three days of differentiation, 36% of the cells that expressed
the neuronal marker were proliferating. After six days of
differentiation the percentage of proliferating immature neurons
had declined, but still 13% of the neurons incorporated BrdU.
The myelin-associated inhibitors Nogo-A, myelin-associated
glycoprotein (MAG) and oligodendrocyte myelin glycoprotein
(OMgp) share two common receptors; the Nogo-66 receptor
(together with its co-receptors p75
NTR, TROY and LINGO-1)
and the paired immunoglobulin-like receptor B (PirB). It is well-
known that these proteins impair neuronal regeneration by
limiting axonal sprouting and have received much attention as
promising treatment targets for e.g. traumatic brain injury, spinal
cord injury and stroke [19,21,28,30,31,32,33]. LINGO-1 upregu-
lation has been demonstrated in oligodendrocyte progenitor cells
in MS lesions, in dopaminergic neurons in patients with
Parkinson’s disease and in rat spinal cord after injury
[27,28,32,34]. It has been shown that mice deficient in LINGO-
1 or treated with LINGO-1 neutralizing antibodies exhibit
increased remyelinisation in experimental autoimmune encepha-
lomyelitis (EAE), a model of immune-mediated demyelinisation
[21]. In another study, an LINGO-1 antagonist was demonstrated
to promote CNS remyelinisation by directly stimulating OPC
differentiation in nonimmune, toxin-induced models of demyelin-
ation in rats [29]. Moreover, it has been shown that neutralization
of LINGO-1 has a positive effect of cell survival in animal models
of various CNS disorders including spinal cord injury, MS and
Parkinson’s disease and LINGO-1 inhibitors are currently
evaluated as a treatment option for MS [19,34,35]. The possible
effect of LINGO-1 neutralization on cell survival in differentiating
NSPC cultures was investigated by TUNEL assay and Western
blot analysis of phosphorylated PKB/Akt. Our TUNEL stainings
revealed that the amount of cells going through apoptosis during
the early phase of differentiation (1 and 3 days following growth
factor withdrawal) was significantly decreased in cultures treated
with LINGO-1 ab. However, there was no increase in phosphor-
ylated PKB/Akt in LINGO-1 neutralized cultures, indicating that
other cell death pathways, possibly associated with p75
NTR or
RhoA, might be involved [34,36].
Recent studies demonstrate that both Nogo and NgR1 are
present on neural stem cells in culture [37,38,39]. The exact role
for myelin-associated inhibitors and their receptors during neural
stem cell differentiation is however still unclear. It has been
reported that Nogo-66 (the axon growth inhibiting domain of
Nogo-A) and MAG could promote astroglial differentiation of
NSPCs [38,40]. In another study, two other regions of Nogo-A
was shown to inhibit neuronal differentiation and promote glial
cell formation [41]. Furthermore, the myelin-associated inhibitor
OMgp has been shown to be expressed by cultured NSPCs and
over expression of OMgp in NSPC cultures had a negative effect
cell proliferation [42].
Our present investigation demonstrates a striking effect of
LINGO-1 neutralization on NSPCs differentiation, resulting in an
expansion of the pool of immature neurons. The long-term effect
of LINGO-1 neutralization, however, remains to be elucidated. It
is possible that the proliferating, immature neurons eventually
differentiate into mature neurons (although slower than neurons in
the control cultures). Our results highlight the possibility to use
LINGO-1 inhibitors in combination with stem cell transplanta-
tions or in order to promote endogenous neurogenesis following
CNS insults or neurodegenerative disorders. For clinical reasons it
is of course necessary to investigate if the neuroblasts that are
proliferating in the presence of LINGO-1 ab give rise to functional
neurons in vivo. Several investigations demonstrate an involvement
of LINGO-1 in neurodegenerative processes including Alzhei-
mer’s disease [43], Parkinson’s disease [28] and multiple sclerosis
[21]. In order to develop therapeutic strategies based on LINGO-1
neutralization it is necessary to understand the basic biology of
LINGO-1 and its effect on the different CNS cell types.
Materials and Methods
Anti-LINGO-1 antibody
To neutralize LINGO-1 during NSPC differentiation we used a
human anti-LINGO-1 monoclonal antibody provided by Novartis
Inc. Basel, Switzerland [44]. Based on previous cell culture studies
using anti-LINGO-1 ab we tested four different concentrations; 1,
10, 100 and 1000 mg/ml [20,28,29]. The effect of the different
concentrations was similar, but the most pronounced effect on
neuronal differentiation was found using the higher concentra-
tions, 100 mg/ml and 1000 mg/ml. In culture treated with
1000 mg/ml the cells were more often found in clusters (Figure
S1). We chose to use 100 mg/ml throughout the study in order to
maximize the LINGO-1 inhibition (since no side effects were
observed at this concentration). Control (anti-chick lysozyme,
100 mg/ml) antibodies were included in the initial experiments.
Since the control antibody had no effect compared to untreated
controls, plain medium was used as a control in the rest of the
study.
Cell culture
C57/BL6 mice were housed at 24uC in 12 h light/dark cycles
with access to food and water ad libitum in line with the Swedish
animal welfare legislation. The study was specifically approved by
Uppsala Animal Ethics Committee, Uppsala, Sweden (Permit
number: C 234/8) before the study was started. Dissected cortices
from E14 mice were dissociated in GIBCO Hank’s Balanced Salt
Solution (16) supplemented with 8 mM HEPES buffer solution
and 50 units of penicillin and 50 mg of streptomycin per ml
(Invitrogen), hereafter only referred to as HBSS. The cell
suspension was centrifuged and resolved in medium (GIBCO
Dulbecco’s Modified Eagle Medium (D-MEM/F12) with Gluta-
MAX (61) supplemented with 50 units/ml
21 penicillin and
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21 streptomycin, 8 mM HEPES buffer, 16B-27 serum
free supplement) fortified with 10 ng ml
21 Fibroblast Growth
Factor 2 (FGF2) (Invitrogen) and 20 ng ml
21 natural mouse
Epidermal Growth Factor (EGF) (Becton Dickinson). The cells
were grown non-adherently into neurospheres and passaged every
3
rd to 5
th day by dissociation in HBSS and resuspension in new
medium supplemented with mitogens at concentrations previously
described. Prior to each experiment, cells were dissociated in
HBSS and plated as a monolayer on coverslips coated with poly-L-
ornithine (Sigma-Aldrich Inc.) and laminin (Invitrogen). The first
day cells were maintained in EGF and FGF2 supplemented
medium (to recover from the passage) and thereafter replaced with
mitogen-free medium to initiate cell differentiation. 100 mg/ml of
LINGO-1 ab was added to the cell culture media and control
cultures received culture media only. Every third day half of the
media was changed to fresh media with or without LINGO-1 ab.
NSPCs from passage 1–3 were used for the study.
Immunocytochemistry
Primary antibodies used in the study included: Tubulin beta III
isoform (bIII tubulin, 1:200, CHEMICON International) pro-
duced in mouse, rabbit antibody to Glial Fibrillary Acidic Protein
(GFAP, 1:400, DakoCytomation), 29,39-cyclic nucleotide 39-
phosphodiesterase (CNPase, 1:500, Sigma) produced in mouse
and human LINGO-1 (1:100, Novartis, 1:200 AbCam). Second-
ary antibodies (IgG) used were: AlexaFluor 488-conjugated
antibody to rabbit, mouse or human (1:200, Molecular Probes)
and Cy3-conjugated mouse or rabbit antibody (Sigma-Aldrich).
Cell culture coverslips were fixed in 4% paraformaldehyde (PFA)
and permeabilized and blocked for 30 min in 0.1% Triton X-100
(vol/vol, Sigma) and 5% natural goat serum (NGS) (vol/vol) in
PBS. For LINGO-1 stainings Triton-X-100 was excluded.
Incubation of primary antibodies was performed in either RT
for 1–4 h or overnight in 4uC. Coverslips were washed three times
in PBS before incubation with secondary antibody for 1 h in 37uC.
The samples were washed three times before mounted with
Vectashield Hard Set mounting medium, with or without 49,6-
diamidino-2-phenylinodole (DAPI, Vector).
Proliferation assay
Cells were seeded on precoated culture dishes as described
above. After withdrawal of FGF2 and EGF, 100 mg/ml of
LINGO-1 ab was added to the cell culture media and control
cultures received culture media only. For studying cell prolifera-
tion, cells were pulsed with Bromodeoxyuridine (BrdU) (1:1000,
Amersham Cell Proliferation Kit, GE Healthcare) 16 hours before
fixation at day 0, 1, 3 and 6 days after withdrawal of FGF2 and
EGF. Cells were fixed in ice-cold acid ethanol and nuclease/anti-
5-bromo-29deoxyuridine (1:100; Amersham Cell Profileration Kit)
were added to coverslips and incubated for 1 h at room
temperature. Coverslips were washed three times in PBS and
incubated with secondary antibody (1:200; anti-mouse Alexa
Flour, Invitrogen) for 1 h. Coverslips were washed three times in
PBS and mounted on glass slides with Vechtashield containing
DAPI (Vector).
Terminal Deoxynucleotidyl transferase dUTP nick end
labeling assay
Cells were seeded on precoated culture dishes as described
above. After withdrawal of FGF2 and EGF, 100 mg/ml of anti-
LINGO-1 antibody was added to the cell culture media and
control cultures received culture media only. Cells were fixed in
4% PFA at day 0, 1, 3 and 6 after withdrawal of FGF2 and EGF,
and TUNEL labeled as instructed by the manufacturer (Roche
Applied Science). Coverslips were mounted on glass slides with
Vechtashield containing DAPI (Vector).
Fluorescence microscopy
The glass slides were analyzed using a fluorescence microscope
(AxioVision, Zeiss) with the magnitude of 206. Eight different
representative fields per glass slide were photographed and the
labeled cells were counted. Different immunostainings, prolifera-
tion assay and TUNEL assay were performed in triplicates at
minimum three times.
Total cell counting
Total cell counting was made using a NucleoCounter
TM
(Chemometec A/S, Denmark). Cells were cultured in the presence
or absence of LINGO-1 ab on precoated 35 mm cell culture
plates. At day 0, 1, 3 and 6 after withdrawal of FGF2 and EGF
cells were harvested from the dishes by scraping and dissociated in
PBS (1:3, Invitrogen), lysis buffer (1:3; Chemometec) and
stabilizing buffer (1:3; Chemometec). The suspensions were
vortexed and directly introduced into the NucleoCassettes
TM
(Chemometec) and run in the NucleoCounter
TM. The experiment
was performed in triplicate and repeated three times.
Sphere formation assay
To form a cell suspension with single cells, spheres were
centrifuged for 3 min at 900 rpm and the pellet was dissolved in
10 ml preheated HBSS and incubated rotating at 37uC for
15 min. The spheres were centrifuged for 3 min at 900 rpm and
dissociated in cell culture media. Single cells, 10 cells/ml, were
cultured in media containing FGF2 and EGF and LINGO-1 ab.
LINGO-1 ab were also added to the wells without FGF2 and
EGF. Wells without LINGO-1 ab and with FGF2 and EGF
respective without FGF2 and EGF were used as controls. The cells
were incubated at 37uC for 8 days where after the number of
spheres in each well was counted. The experiment was performed
in triplicates.
Western blot analysis: Immunoprecipitation
At day 0, 1, 3 and 6 after withdrawal of FGF2 and EGF the
media was removed and protein lysates preparation was made.
Lysis buffer (20 mM Tris pH 7.5, 0.5% Triton-X-100, 0.5%
Deoxycholic acid, 150 mM NaCl, 10 mM EDTA, 30 mM
NaPyroP) supplemented with 15% protease inhibitor cocktail
(Roche) and sodium orthovanadate (Na3VO4) (0.1 M, Sigma) was
added to the Petri dishes and the cells were removed by scraping.
The cell lysates were kept on ice for 30 min followed by
centrifugation at 120006 g for 30 min at 4uC. The supernatant
was collected and the protein concentration of the samples was
determined in triplicates using Pierce BCA Protein Assay Kit
(Thermo Scientific) and ELISA. Before separating proteins using
SDS-PAGE, immunoprecipitation was done using 200 mg protein
of each sample. Protein G beads (Invitrogen) were prewashed 3
times in PBS and 1 time in lysis buffer. Immune complexes were
formed by adding 20 mg LINGO-1-ab (Novartis) to 100 ml beads
followed by 2 h incubation at 4uC. The Protein G-ab immune
complex was washed in lysis buffer, added to the cell lysates and
incubated at 4uC over night. The protein G-ab-protein complexes
were washed 2 times in lysis buffer and 1 time in PBS. The samples
were boiled in 26SDS Laemmli buffer (Sigma) at 95uC for 5 min
before loaded on the SDS-PAGE gel (NuPAGE 4–12% Bis Tris
Gel, Invitrogen). The gel was run at 200 V for 35 min in
NuPAGE MES buffer (Invitrogen). The proteins were blotted
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for 5 min and for 10 min in transfer buffer (Invitrogen).
Transferring was done at 25 V, 120 mA for 100 min. The filter
was blocked in 5% BSA in 0.2% Tween in PBS (PBS-T) for
60 min and then washed 2 times in 0.2% PBS-T. The filter was
incubated with primary antibody (anti-LINGO-1-antibody,
0.4 mg/ml, Abcam) in 0.5% BSA and 0.2% PBS-T at 4uC over
night. After washing, the filter was incubated with peroxidase-
conjugated secondary antibody for 1 h at RT, washed in PBS-T
and developed using enhanced chemiluminescence (ECL) system
(GE Healthcare).
Western blot analysis: Total lysate
Protein lysates were prepared by incubating the cells in lysis
buffer (20 mM Tris pH 7.5, 0.5% Triton-X-100, 0.5% Deoxy-
cholic acid, 150 mM NaCl, 10 m M EDTA, 30 mM NaPyroP)
supplemented with 15% protease inhibitor cocktail (Roche) and
sodium orthovanadate (Na3VO4) (0.1 M, Sigma) on ice for 30 min
prior to 30 min centrifugation at 120006ga t4 uC. 30 mg protein
was loaded on a SDS-PAGE gel (NuPAGE 4–12% Bis Tris Gel,
Invitrogen) and the gel was run at 200 V for 90 min in NuPAGE
MES buffer (Invitrogen). The proteins were blotted using a PVDF
filter (0.2 mm, Invitrogen) pretreated in methanol for 5 min and
for 10 min in transfer buffer (Invitrogen). Transferring was done at
25 V, 120 mA for 100 min. The filter was blocked in 5% BSA in
0.2% PBS-T for 60 min and then washed 2 times in PBS-T prior
to incubation with primary antibody in 0.5% BSA and 0.2% PBS-
Ta t4 uC over night. Primary antibodies were: rabbit-anti-PKB/c-
Akt (Cell Signaling Technology), diluted 1:1000 and rabbit-anti-
phosphorylated PKB/c-Akt (Cell Signaling Technology), diluted
1:1000. After washing, the filter was incubated with peroxidase-
conjugated secondary antibody for 1 h at RT, washed in PBS-T
and developed using enhanced chemiluminescence (ECL) system
(GE Healthcare). Before rehybridization the filter was dehybri-
dized in 0.4 M NaOH at RT for 10 min and washed 465 min in
PBS-T.
Statistics
The results are expressed as means 6 standard error of the
mean (sem). All data in the study were first tested for normality
using Shapiro-Wilk test, showing non-normal distribution. The
levels of significance were then determined by the non parametric
Mann-Whitey tests (p,0.05 was designated with one asterisk,
p,0.01 was designated with two asterisks and p,0.001 designated
with three asterisks). All statistical analyses were performed using
GraphPad Prism 5 (GraphPad Software, Inc., CA, USA).
Supporting Information
Figure S1 Two different LINGO-1 antibodies identify
the same cells. Double immunostainings show that the Novartis
antibody and a LINGO-1 antibody purchased from Abcam
identify the same LINGO-1 expressing cells. Differentiated NSPCs
cultures were fixed at day 6 after mitogen withdrawal. Scale
bars=20 mm.
(TIF)
Figure S2 Dose-Reponse effect of LINGO-1 neutraliza-
tion during NSCP differentiation. To investigate the effect of
different concentrations of the LINGO-1 antibody on neuronal
differentiation, NSPCs were cultured for 6 days in the presence of
1, 10, 100 or 1000 mg/ml LINGO-1 ab (Novartis) following
mitogen withdrawal. Control cultures were left untreated or were
treated with 100 mg/ml control, anti-lyszyme antibody. The cells
were fixed and stained with specific antibodies against bIIItubulin.
In untreated cultures and cultures treated with the control
antibody, neurons were rather mature with multiple, long
extending processes. Already in cultures treated with 1 or
10 mg/ml LINGO-1 antibodies the neurons had clearly a more
immature phenotype. In cultures treated with 100 or 1000 mg/ml
LINGO-1 antibody the difference to control cultures were more
pronounced and the neurons in these cultures had very short
processes. At the highest concentration the neurons were more
often found in clusters. Scale bars=20 mm.
(TIF)
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